Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy

BACKGROUND: Pretreatment and on‐treatment plasma cytokine levels in predicting clinical benefit in patients with advanced non‐small cell lung cancer (NSCLC) treated with anti‐programmed death‐1 (PD‐1)‐based chemotherapy is still a matter of debate. METHODS: We measured 12 kind of plasma cytokines in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuequan, Liu, Xiaoyan, Du, Juan, Zhang, Dongming, Liu, Jia, Chen, Minjiang, Zhao, Jing, Zhong, Wei, Xu, Yan, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758427/
https://www.ncbi.nlm.nih.gov/pubmed/34825500
http://dx.doi.org/10.1111/1759-7714.14248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758427/
https://www.ncbi.nlm.nih.gov/pubmed/34825500
http://dx.doi.org/10.1111/1759-7714.14248

Ejemplares similares